Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation

Hong Xiang, Fangyue Guo, Xufeng Tao, Qi Zhou, Shilin Xia, Dawei Deng, Lunxu Li, Dong Shang

Theranostics · 2021 · 63 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

Our study showed the important regulatory effect of S100A9 on pancreatic duct injury during AP and revealed that inhibition of the S100A9-VNN1 interaction may be a key therapeutic target for this disease.